Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Based on Immune Microenvironment and Genomic Status, Exploring Immunotherapy in Advanced Hidradenocarcinoma: A Retrospective Analysis.

Acta dermato-venereologica - 13 May 2024

Lin Jing, Zhu Li, Chen Yanping, Li Qian, Ke Zhiheng, Zhang Huishan, Huang Yufang, Lu Jianping, Chen Yu

Abstract excerpt

There are no standard treatment guidelines for hidradenocarcinoma, and the immune microenvironment and genomic data are very limited. Thus, in this study the immune microenvironment and genomic indicators in hidradenocarcinoma was investigated, and immunotherapy for hidradenocarcinoma was initially explored. Forty-seven hidradenocarcinoma patients were retrospectively collected. Immunohistochemical staining was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Immunological
Share to B7-H1 Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Immunotherapy

Share to Lymphocytes, Tumor-Infiltrating

Share to Treatment Outcome

Share to Tumor Microenvironment

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 38738772
DOI: 10.2340/actadv.v104.22146
PMCID: PMC11107830

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Based on Immune Microenvironment and Genomic Status, Exploring Immunotherapy in Advanced Hidradenocarcinoma: A Retrospective Analysis.PMID 38738772Read ↗

Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers.Semantic proximity Read ↗

Distinct genomic landscapes of gastroesophageal adenocarcinoma depending on PD-L1 expression identify mutations in RAS-MAPK pathway and TP53 as potential predictors of immunotherapy efficacy.Semantic proximity Read ↗

Classification of primary liver cancer with immunosuppression mechanisms and correlation with genomic alterationsSemantic proximity Read ↗

Classification of tumor microenvironment immune types based on immune response-associated gene expressionSemantic proximity Read ↗

Tumors of the Digestive System: Comprehensive Review of Ancillary Testing and Biomarkers in the Era of Precision Medicine.Semantic proximity Read ↗

Genetic mutation profiles and immune microenvironment analysis of pulmonary enteric adenocarcinoma.Semantic proximity Read ↗

Prognostic significance of NUAK1 and its association with immune infiltration in stomach adenocarcinomaSemantic proximity Read ↗

Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification.Semantic proximity Read ↗

High tumor mutational burden (TMB) identifies a microsatellite stable pancreatic cancer subset with prolonged survival and strong anti-tumor immunity.Semantic proximity Read ↗

Reversing immunosuppression in the tumor microenvironment of fibrolamellar carcinoma via PD-1 and IL-10 blockadeSemantic proximity Read ↗

Reversible Downregulation of HLA Class I in Adenoid Cystic CarcinomaSemantic proximity Read ↗

Genetic/Epigenetic Alteration and Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Transforming the Immune Microenvironment with Molecular-Targeted AgentsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.